Vesedaganat: vizsgálatok itt: Olaszország
30 of 48 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Bari, Bologna, Florence, Meldola, Milan, Padova, Perugia, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - 3. fázisTaking peopleA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Where
- Arezzo, Bari, Bologna, Florence, Genoa, Milan, Naples, Orbassano, Padova, Parma, Peschiera del Garda, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 904 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00 - No phaseTaking peopleClinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell Carcinoma
- Where
- Milan
- Életkor
- 18 év and over
- People
- 124
- Run by
- Niguarda Hospital
See details and how to joinNCT07234409 - 3. fázisTaking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Bari, Florence, Genoa, Lecce, Macerata, Milan, Naples, Padova, Parma, Perugia, Pisa, Rome, Rozzano, Terni, Turin, Verona
- Életkor
- 18 év and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - No phaseTaking peopleStereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer
- Where
- Milan
- Életkor
- 18 év and over
- People
- 60
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07285538 - 1/2. fázisNot yet taking people in OlaszországA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Milan, Naples, Verona
- Életkor
- 18 év and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - 1. fázisTaking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Bologna, Candiolo, Naples, Rozzano, Verona
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - 1. fázisTaking peopleA Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Where
- Bologna, Milan, Rome, Verona
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07195916 · EU 2025-523130-11-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Ancona, Bologna, Florence, Milan, Naples, Ravenna
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 1. fázisNot yet taking people in OlaszországA Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Roma, Rozzano
- Életkor
- 18 év and over
- People
- 112 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07848295 - 3. fázisTaking peopleCARE1: FIRST LINE RANDOMISED STUDY PLATFORM TO OPTIMIZE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
- Where
- Aviano, Bari, Bologna, Brescia, Cremona, Florence, Genoa, Milan, Modena, Naples, Padova, Parma, Pavia, Reggio Emilia, Rome, Terni, Verona
- Életkor
- 18 év and over
- People
- 1373 worldwide
- Run by
- Institut Gustave Roussy
See details and how to join2023-503317-29-00 - 2. fázisNot yet taking people in OlaszországActivity of Pembrolizumab plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma (REPRINT MeetURO trial)
- Where
- Milan
- Életkor
- 18 év and over
- People
- 23
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2024-511587-93-00 - No phaseTaking peopleIntensified Monitoring of PhArmacology of Cabozantinib as a Tool for Toxicity Management in Patients With Renal Cell Carcinoma
- Where
- Aviano
- Életkor
- 18 év and over
- People
- 216
- Run by
- Centro di Riferimento Oncologico - Aviano
See details and how to joinNCT07805122 - 3. fázisNot yet taking people in OlaszországSequence Strategy of Immuneoncology (IO-IO) vs IO-tyrosine kinase inhibitors (TKI) followed by TKI in metastatic renal cell carcinoma (mRCC): A randomized phase 3 study Meet uro and FICOG trial. COMBO-Seq trial.
- Where
- Alba, Arezzo, Aviano, Bari, Carpi, Cremona, Florence, Latina, Lecce, Legnano, Meldola, Milan, Modena, Naples, Novara, Orbassano, Padova, Palermo, Parma, San Giovanni Rotondo, Turin, Varese
- Életkor
- 18 év and over
- People
- 500
- Run by
- Fondazione IRCCS Istituto Nazionale Dei Tumori
See details and how to join2025-523903-31-00 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Candiolo, Milan, Naples, Roma, Rozzano, Siena
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 1. fázisNot yet taking people in OlaszországA First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Rome, Verona
- Életkor
- 18 év and over
- People
- 281 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07195682 · EU 2025-522543-18-00 - 4. fázisTaking peopleIntensified Monitoring of PhArmacology of Cabozantinib as a tool for Toxicity management in patients with renal cell carcinoma
- Where
- Aviano, Bolzano
- Életkor
- 18 év and over
- People
- 216
- Run by
- Centro Di Riferimento Oncologico Di Aviano
See details and how to join2026-525267-40-00 - 2. fázisNot yet taking people in OlaszországPhase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
- Where
- Milan, Padova, Rome
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- Advenchen Pharmaceuticals, LLC.
See details and how to joinNCT05363280 · EU 2023-509067-24-01 - 1. fázisNot yet taking people in OlaszországA Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With Ruxolitinib in Patients With Advanced Solid Tumors
- Where
- Rome
- Életkor
- 18 év to 75 év
- People
- 96
- Run by
- Philogen S.p.A.
See details and how to joinNCT07566897 · EU 2025-522243-17-00 - 1/2. fázisNot yet taking people in OlaszországA First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Where
- Milan, Naples, Rome, Verona
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06413680 · EU 2025-523399-22-00 - 4. fázisTaking peopleCLINICAL AND HUMORAL IMPACT OF PRIMARY TUMOR ABLATION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH IMMUNOTHERAPY.THE ITALIC-RCC RANDOMIZED STUDY
- Where
- Arezzo, Asti, Bari, Bergamo, Bologna, Brescia, Catania, Catanzaro, Florence, Frattamaggiore, Lecce, Macerata, Meldola, Milan, Modena, Naples, Novara, Orbassano, Padova, Parma, Perugia, Pisa, Ravenna, Reggio Emilia, Rome, Rozzano, San Giovanni Rotondo, Terni, Trento, Turin, Verona
- Életkor
- 18 év and over
- People
- 409
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to join2024-517789-41-00 - 2. fázisTaking peoplePembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
- Where
- Milan
- Életkor
- 18 év and over
- People
- 23
- Run by
- Giuseppe Procopio
See details and how to joinNCT06302569 - 4. fázisTaking peoplePrimary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
- Where
- Roma
- Életkor
- 18 év and over
- People
- 409
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06903312 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Ancona, Bologna, Meldola, Milan, Padova, Turin
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - 3. fázisVisszavonvaA Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- Where
- Candiolo, Catania, Meldola (FC), Milan, Naples, Novara, Pavia, Pisa, Roma
- Életkor
- 18 év and over
- People
- 413 worldwide
- Run by
- Xynomic Pharmaceuticals, Inc.
See details and how to joinNCT03592472